Double-masked Study of PG324 Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension
Phase of Trial: Phase III
Latest Information Update: 31 Jul 2017
At a glance
- Drugs Latanoprost/netarsudil (Primary) ; Latanoprost; Netarsudil
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Registrational; Therapeutic Use
- Sponsors Aerie Pharmaceuticals
- 25 Jul 2017 Status changed from recruiting to completed.
- 28 Apr 2016 Status changed from not yet recruiting to recruiting.
- 17 Feb 2016 New trial record